Skip to Main Content

Author Details

Doroth??e Leroux
Hopitaux Universitaires de Strasbourg
2010
14
10
PMIDPaper TitleJournal TitlePublished Year
36878196Current Management of Patients with RPE65 Mutation Associated Inherited Retinal Degenerations in Europe: Results of a 2-Year Follow-Up Multinational Survey.Ophthalmic Res2023
36592621Current Management of Inherited Retinal Degeneration Patients in Europe: Results of a 2-Year Follow-Up Multinational Survey by the European Vision Institute Clinical Research Network - EVICR.net.Ophthalmic Res2023
30476213Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources.Nucleic Acids Res2019
31416457Correction to: An ontological foundation for ocular phenotypes and rare eye diseases.Orphanet J Rare Dis2019
30626441An ontological foundation for ocular phenotypes and rare eye diseases.Orphanet J Rare Dis2019
25680756Increased risk of thrombosis in FcγRIIA 131RR patients with HIT due to defective control of platelet activation by plasma IgG2.Blood2015
24074968[Heparin-induced thrombocytopenia: recent data].Rev Med Interne2014
24815503Prospective evaluation of a rapid nanoparticle-based lateral flow immunoassay (STic Expert(®) HIT) for the diagnosis of heparin-induced thrombocytopenia.Br J Haematol2014
23621699Impact of polymorphisms affecting the ACP1 gene on levels of antibodies against platelet factor 4-heparin complexes.J Thromb Haemost2013
23636177Incidence of antibodies to protamine sulfate/heparin complexes incardiac surgery patients and impact on platelet activation and clinical outcome.Thromb Haemost2013
22235911Binding of heparin-dependent antibodies to PF4 modified by enoxaparin oligosaccharides: evaluation by surface plasmon resonance and serotonin release assay.J Thromb Haemost2012
22677127Polymorphisms of protein tyrosine phosphatase CD148 influence FcγRIIA-dependent platelet activation and the risk of heparin-induced thrombocytopenia.Blood2012
22239992Interleukin-10 promoter microsatellite polymorphisms influence the immune response to heparin and the risk of heparin-induced thrombocytopenia.Thromb Res2012
20062918Effectiveness of a new immunoassay for the diagnosis of heparin-induced thrombocytopenia and improved specificity when detecting IgG antibodies.Thromb Haemost2010
  • 1 - 14 of 14

Recommended Authors

Vanderbilt University Medical Center
Career Start Year 2016
Number of shared co-authors 0
Department of Pharmaceutical and Pharmacological Sciences, University of Padova
Career Start Year 2012
Number of shared co-authors 0
Washington University in St. Louis School of Medicine
Career Start Year 2011
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2009
Number of shared co-authors 0
Christian Medical College
Career Start Year 2007
Number of shared co-authors 0
Yale University School of Medicine, Yale-New Haven Hospital
Career Start Year 2007
Number of shared co-authors 0
University of New Mexico
Career Start Year 2006
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 2006
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 2000
Number of shared co-authors 0
University of Minnesota
Career Start Year 1999
Number of shared co-authors 0
Tokyo Medical and Dental University
Career Start Year 1998
Number of shared co-authors 0
Center for Molecular and Vascular Biology, University of Leuven
Career Start Year 1998
Number of shared co-authors 23
NewYork-Presbyterian/Columbia University Irving Medical Center
Career Start Year 1997
Number of shared co-authors 0
Yale University School of Medicine
Career Start Year 1996
Number of shared co-authors 0
Novartis Pharma
Career Start Year 1995
Number of shared co-authors 0
University of Wisconsin School of Medicine and Public Health
Career Start Year 1994
Number of shared co-authors 0
Mayo Clinic
Career Start Year 1992
Number of shared co-authors 0
Clinical Services
Career Start Year 1991
Number of shared co-authors 0
University of Minnesota
Career Start Year 1990
Number of shared co-authors 0
Oregon Health & Science University
Career Start Year 1990
Number of shared co-authors 0
University of Bristol
Career Start Year 1989
Number of shared co-authors 10
Mayo Clinic
Career Start Year 1988
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 1986
Number of shared co-authors 0
Institut Universitaire de Cancerologie (IUC), Sorbonne Universite
Career Start Year 1985
Number of shared co-authors 0
Yale School of Medicine
Career Start Year 1984
Number of shared co-authors 0
Stony Brook Renaissances School of Medicine, Stony Brook University
Career Start Year 1984
Number of shared co-authors 0
University of Cambridge
Career Start Year 1984
Number of shared co-authors 23
Duke University Medical Center
Career Start Year 1983
Number of shared co-authors 0
University of NSW
Career Start Year 1979
Number of shared co-authors 0
Haemacon Ltd
Career Start Year 1976
Number of shared co-authors 0

Collaborators

Institut de Genetique Medicale d'Alsace, Hopitaux Universitaires de Strasbourg
Co-authored papers 5
Children's Hospital of Eastern Ontario Research Institute
Co-authored papers 3
University of Manchester
Co-authored papers 3
INSERM
Co-authored papers 3
William Harvey Research Institute, Queen Mary University of London
Co-authored papers 3
INSERM
Co-authored papers 3
Institute of Molecular and Clinical Ophthalmology Basel
Co-authored papers 2
University Eye Hospital, University of Tubingen
Co-authored papers 2
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Instituto Politecnico Nacional
Co-authored papers 1
American Medical Informatics Association, Oregon Health and Science University, Oregon State University, University of Colorado Anschutz Medical Campus, University of North Carolina at Chapel Hill, University of Wisconsin-Madison
Co-authored papers 1
Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust
Co-authored papers 1
Curtin University
Co-authored papers 1
William Harvey Research Institute, Queen Mary University of London
Co-authored papers 1
Columbia University
Co-authored papers 1
William Harvey Research Institute, Queen Mary University of London
Co-authored papers 1
Vrije Universiteit Brussel
Co-authored papers 1
King Edward Memorial Hospital
Co-authored papers 1
SD Sanford School of Medicine, University of South Dakota
Co-authored papers 1
Renaissance Computing Institute, University of North Carolina
Co-authored papers 1
National Center for Advancing Translational Sciences, National Institutes of Health
Co-authored papers 1
William Harvey Research Institute, Queen Mary University of London
Co-authored papers 1
Co-authored papers 1
Hospital Universitari Vall d'Hebron
Co-authored papers 1
Stanford University
Co-authored papers 1
Critical Path Institute
Co-authored papers 1
Lawrence Berkely National Laboratory, Massachusetts Institute of Technology, Princeton University
Co-authored papers 1
Linus Pauling institute, Oregon State University
Co-authored papers 1